2025 and Degenerative Disc Disease - Chiropractic Pulse

Search:

DAY

WEEK

MONTH

YEAR

Jul 19 - Jul 25

Jul 12 - Jul 18

Jul 05 - Jul 11

Jun 28 - Jul 04

MORE

MORE

MORE

MORE

Select your country:
Sign up | Log in

2025

Degenerative Disc Disease

article thumbnail

ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain

OrthoSpineNews

JUNE 18, 2025

BALTIMORE, June 18, 2025 -( BUSINESS WIRE )- ReGelTec Inc. , I am excited to be working with ReGelTec and the other principal investigators to enroll the HYDRAFIL-D Study and evaluate the impact of HYDRAFIL on patients with degenerative disc disease.” Walnut Creek, Calif.; Greenwood Village, Colo.; Jasper, Ga.;

Degenerative Disc Disease

Degenerative Disc Disease Clinic Patients Vertebrae

article thumbnail

Study Confirms Significant Clinical Benefit of Neo Medical’s Force Control Technology™ in Spinal Fusion Surgery

OrthoSpineNews

APRIL 1, 2025

About the Study The clinical study involved 75 patients undergoing thoracolumbar fusion surgery to treat conditions including trauma, spinal stenosis, and degenerative disc disease. 2025) 196:123812. Key Study Findings: 3.4x lower rate of screw loosening (2.7% after one year 3.4 times lower than the 9.2% World Neurosurg.

Degenerative Disc Disease

Degenerative Disc Disease Clinic Spine Treatment

Join 5,000+

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dymicron Granted IDE Approval for Triadyme-C Artificial Disc

OrthoSpineNews

JULY 10, 2025

OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron ® , a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) spine centers, with the first implantations expected in Q4 2025. Dymicron’s Triadyme-C achieves critical milestone to begin U.S.

Degenerative Disc Disease

Degenerative Disc Disease Spine Clinic Patients

article thumbnail

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

OrthoSpineNews

MAY 13, 2025

May 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. MELVILLE, N.Y.,

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Clinic Treatment

article thumbnail

Groundbreaking Spine Surgery Performed by Dr. Ehsan Jazini Marks New Era in Motion-Preserving Procedures

OrthoSpineNews

JUNE 25, 2025

First in the Nation to Perform Custom Combination of prodisc® C Nova and prodisc® C VIVO Disc Replacement. June 25, 2025 /PRNewswire/ — VSI® proudly announces a groundbreaking achievement in spine surgery, led by nationally recognized spine surgeon Dr. Ehsan Jazini. RESTON, Va.,

Degenerative Disc Disease

Degenerative Disc Disease Spine Neck Pain Musculoskeletal

article thumbnail

Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device

OrthoSpineNews

MARCH 3, 2025

Spine Surgeon Dr. Frank Phillips Joins SST Board of Directors SAN ANTONIO, March 3, 2025 /PRNewswire/ — Spinal Stabilization Technologies, LLC (SST) has announced a significant milestone in its mission to revolutionize spinal care: the enrollment of the first U.S. Pierce Nunley completes the first U.S. PerQdisc Surgery.

Degenerative Disc Disease

Degenerative Disc Disease Patients Spine Clinic

article thumbnail

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration

OrthoSpineNews

JULY 29, 2025

Data readout expected in Q1 2026 MIAMI, July 29, 2025 (GLOBE NEWSWIRE) — Vivex Biologics, Inc.,

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Physical therapy Clinic

article thumbnail

BioRestorative Announces Share Repurchase Program

OrthoSpineNews

JUNE 17, 2025

June 17, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. MELVILLE, N.Y., We have also obtained U.S.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Clinic Treatment

article thumbnail

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

OrthoSpineNews

JUNE 23, 2025

June 23, 2025 /PRNewswire/ — Cerapedics Inc., Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD).

Degenerative Disc Disease

Degenerative Disc Disease Spine Vertebrae Treatment

article thumbnail

Xtant Medical Announces Definitive Agreements for the Sale of its Coflex® and CoFix® Spinal Implants and All OUS Businesses to Companion Spine

OrthoSpineNews

JULY 8, 2025

July 8, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. The transaction is expected to close in the third quarter of 2025. The promissory note will mature on December 31, 2025. Transaction expected to facilitate enhanced focus on Xtant’s core businesses Total consideration of approximately $19.2

Spine

Spine Degenerative Disc Disease Musculoskeletal Treatment

article thumbnail

Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval

OrthoSpineNews

JULY 8, 2025

July 8, 2025 /PRNewswire/ — Cerapedics Inc., The first post-approval procedure on an adult patient with degenerative disc disease (DDD) was performed by neurosurgeon Sharad Rajpal, M.D., WESTMINSTER, Colo., Medical Director of the Advanced Spine Program at AdventHealth Avista in Louisville, Colorado.

Degenerative Disc Disease

Degenerative Disc Disease Patients Spine Vertebrae

article thumbnail

Spine BioPharma, Inc. to Present at Biotech Showcase 2025

OrthoSpineNews

JANUARY 7, 2025

January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc., January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc.,

Degenerative Disc Disease

Degenerative Disc Disease Spine Prevention Treatment

article thumbnail

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

OrthoSpineNews

MAY 14, 2025

May 14, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. BioRestorative, BRTX or the Company) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its business.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Neck Pain Treatment

article thumbnail

Aurora Spine Corporation Announces Completion of Enrollment in Groundbreaking REFINE Study: First Prospective, Multi-Center, Multi-Specialty Study on Lumbar Interlaminar Fusion

OrthoSpineNews

MARCH 10, 2025

The results will be presented at the American Society of Pain and Neuroscience (ASPN) annual conference in July 2025, spotlighting Aurora Spines commitment to evidence-based innovation. CARLSBAD, Calif., CARLSBAD, Calif., We are incredibly proud to reach this milestone, said Trent Northcutt, President and CEO of Aurora Spine.

Degenerative Disc Disease

Degenerative Disc Disease Spine Musculoskeletal Clinic

article thumbnail

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

OrthoSpineNews

JUNE 13, 2025

June 13, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. This data was shared at the prestigious ISSCR 2025 Annual Meeting in Hong Kong by Francisco Silva, Vice President of Research and Development. We have also obtained U.S.

Degenerative Disc Disease

Degenerative Disc Disease Lower Back Pain Clinic Treatment

article thumbnail

Global Spine, MIS and VCF Markets to Reach $38B by 2031, Fueled by Robotic Surgery, MIS Growth, and Next-Gen Implants – iData Research

OrthoSpineNews

MAY 6, 2025

VANCOUVER, BC,May 6, 2025/PRNewswire/ – New global reports on the Spine and Vertebral Compression Fracture (VCF) , along with Minimally Invasive Spine Surgery (MIS) markets, from iData Research reveal major shifts reshaping the industry.

Degenerative Disc Disease

Degenerative Disc Disease Spine Health Patients

article thumbnail

Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI’s Impact on Market Trends – Technavio

OrthoSpineNews

FEBRUARY 10, 2025

10, 2025/PRNewswire/ — Report on how AI is redefining market landscape – The global spinal implants market size is estimated to grow byUSD 3.55 billionfrom 2025-2029, according to Technavio. Market growth 2025-2029 USD 3554.5 NEW YORK,Feb. The market is estimated to grow at a CAGR of almost5.3% JAYON IMPLANTS Pvt.

Degenerative Disc Disease

Degenerative Disc Disease Scoliosis Clients Spine

article thumbnail

Prosthetic Disc Nucleus Market Set to Reach $265.8 Million by 2034, TMR Forecasts 8.2% CAGR – TMR Insights

OrthoSpineNews

JANUARY 28, 2025

The trend toward minimally invasive surgeries and innovations in prosthetic discs with high biocompatibility is further fueling market expansion. 28, 2025 (GLOBE NEWSWIRE) — The global Prosthetic Disc Nucleus Market (Markt fr Bandscheibenkernprothesen) has been valued at US$ 110.6

Degenerative Disc Disease

Degenerative Disc Disease Spine Chronic Pain Treatment